We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
Information for drug services to help them prevent, identify, treat and manage wounds in people who inject drugs.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
The Medicines and Healthcare products Regulatory Agency’s (MHRA) Criminal Enforcement Unit (CEU) seized a quantity of suspected unlicensed medical products following coordinated raids at three residential and six business premises in Bolton, Greater Manchester.
'Seizures of drugs in England and Wales: user guide' is designed to be a useful reference guide with explanatory notes on seizure of drugs.
How drug testing (and the related interventions) takes place, when it takes place, and how it is paid for.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
An MHRA and NICE partnership, funded by Wellcome, is addressing key challenges for regulating and evaluating digital mental health technologies (DMHTs) with input from patients, the public and mental health professionals.
Details the government's response to parts 1 and 2 of Dame Carol Black's independent review of drugs.
Actions that trial sponsors should consider to build resilience into clinical trial design
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).